Bristol-Myers Derivative Is Now Worthless as Key Deadline Passes – Bloomberg

https://news.google.com/__i/rss/rd/articles/CBMib2h0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIxLTAxLTAxL2JyaXN0b2wtZGVyaXZhdGl2ZS1yZW5kZXJlZC13b3J0aGxlc3MtYXMta2V5LWRlYWRsaW5lLXBhc3Nlc9IBAA?oc=5

Business - Latest - Google News

Business - Latest - Google News

Related posts

• Zoom Video, Alibaba Among Most Profitable Shorts Since Election Day – Benzinga (0)
• Zoom Video prices $1.75 billion secondary offering at 5% discount – MarketWatch (0)
• Zoom Video Communications Obliterates Quarterly Earnings Estimates – Deadline (0)
• Zoom lied to users about end-to-end encryption for years, FTC says – Ars Technica (0)
• Zoom Founder Drops $5 Billion as Vaccine Hits Covid Winners – Bloomberg (0)
• Zoom and other ‘stay-at-home’ stocks got crushed on the positive vaccine news – CNBC (0)